Thomas Klabunde Selected Research

Long-Acting Insulin (Insulin, Long Acting)

1/2020	In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes.
1/2020	Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes.
10/2019	Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies.
7/2018	Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Klabunde Research Topics

Disease

6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2015
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2005
2	Insulin Resistance 01/2021 - 01/2020
1	Overweight 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2013
1	Hyperglycemia 07/2005
1	Orthostatic Hypotension (Postural Hypotension) 05/2005
1	Lyme Disease (Disease, Lyme) 06/2002

Drug/Important Bio-Agent (IBA)

6	Insulin (Novolin)FDA Link 01/2020 - 01/2015
4	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2020 - 07/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2018
3	Insulin Glargine (Lantus)FDA Link 01/2020 - 10/2019
2	Glucagon Receptors (Glucagon Receptor)IBA 01/2021 - 01/2020
2	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 04/2008 - 07/2005
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Liraglutide FDA Link 01/2021
1	insulin degludecIBA 01/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	C-PeptideIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2013
1	Phosphorylases (Glucan Phosphorylase)IBA 10/2005
1	Liver GlycogenIBA 10/2005
1	alpha-1 Adrenergic Receptors (alpha 1 Adrenergic Receptor)IBA 05/2005
1	Surface Antigens (Surface Antigen)IBA 06/2002
1	Lipoproteins (Lipoprotein)IBA 06/2002

Therapy/Procedure

4	Therapeutics 01/2020 - 07/2018
2	Artificial Pancreas 07/2018 - 01/2015